Concepedia

Kerryn Loftus

KL

Statistics

Publications

1

Citations

21

H-Index

1

Active since

2008

Affiliations

Novartis (Australia)(Current)

Kerryn Loftus is an author at Novartis (Australia) specializing in medicine, maintenance therapy, and oncology.

Publications per year

2008–2008

1

Publications

1

The Majority of Chronic Myeloid Leukaemia Patients Who Cease Imatinib after Achieving a Sustained Complete Molecular Response (CMR) Remain in CMR, and Any Relapses Occur Early.

Davi D M Ross, Andrew Grigg, Anthony P. Schwarer et al. · Blood · 2008 · 21 citations

, , +6

1–1 of 1